ArticleDiscover oncology2026

Integrated ICD-based subtyping and prognostic model reveal KCNN4 as a novel therapeutic target in NSCLC.

Zhengzheng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.